PoreWise

One finding · Human trial · 2025

Study title

Clinical Efficacy of a Salicylic Acid-Containing Gel on Acne Management and Skin Barrier Function: A 21-Day Prospective Study

Kind of evidence
Human trial 2025 · 42 people · people (37 women, 5 men) with mild-to-moderate acne and oily or combination skin, mean age 25.9 · PMID 40682377
Measured outcome
Skin effect
Year
2025
Who was studied
42 people (37 women, 5 men) with mild-to-moderate acne and oily or combination skin, mean age 25.9
Sample size
42
Measured outcome
In a 21-day prospective study of 42 people with mild-to-moderate acne and oily or combination skin, a salicylic-acid-containing gel used twice daily was associated with a 23.65% fall in sebum, a 40.5% rise in skin hydration, a 49.26% fall in transepidermal water loss and a 23.81% improvement in acne grade (all P < 0.05 except IGA P < 0.001).
Certainty
Very low
Who was measured
Sebum, skin hydration, transepidermal water loss and acne grade over 21 days in people with oily or combination skin.
Study limits
One centre, 21 days, 37 of 42 participants were women, and the research group was affiliated with the product maker.

Where it comes from

PMID 40682377

Ingredients it was measured on

Skin concerns studied

Other findings on the same ingredient or concern

  1. Skin effect
    Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial

    In 83 adults with comedones, a serum containing salicylic acid and lipohydroxy acid significantly improved open comedones on the nose, closed comedones on the face, skin pore density, sebum secretion and skin hydration from baseline after 8 weeks; adding a mask improved closed comedones more than the serum alone (-6.56 vs -5.19, p = 0.022).

    Human trial · 2023 · 83 people · adults with comedones (41 serum+mask, 42 serum alone) · Adults in Shanghai with comedones, PIE and PIH, using the serum for 8 weeks. · Both groups used active products; improvements were reported against baseline and between the two active groups. Industry-funded. This is the trial found that counted open and closed comedones separately.

    PMID 36999489

  2. Skin effect
    Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne

    Against topical tretinoin, salicylic acid showed similar values in overall acne improvement (RR 1.00, 95% CI 0.92 to 1.09; one trial, 46 participants). The review graded the certainty of that finding as low.

    Review article · 2020 · 46 people · People with mild to moderate acne, mostly aged 12 to 30 · Topical salicylic acid for mild to moderate acne. Most participants in the review were 12 to 30 years old, and most studies ran longer than eight weeks. · The review covers 49 trials with 3880 participants, salicylic acid appears in a small part of them: 41 to 86 participants per comparison. Every salicylic acid comparison was graded low or very low certainty.

    PMID 32356369

  3. Skin effect
    Guidelines of care for the management of acne vulgaris (2024)

    The 2024 American Academy of Dermatology acne guideline lists topical salicylic acid as a conditional recommendation. Strong recommendations in the same guideline go to benzoyl peroxide, topical retinoids, topical antibiotics and oral doxycycline.

    Clinical guideline · 2024 · Acne vulgaris in people aged nine and older, as covered by the guideline's scope.

    PMID 38300170

  4. Skin effect
    Salicylic Acid (CeraVe ingredient page)

    Salicylic acid is a keratolytic: it loosens the bonds between dead skin cells so they shed.

    Brand claim · Acne and keratolysis, at the concentrations permitted for cosmetic use. · Most evidence comes from leave-on acne treatments. A cleanser is on the skin for a minute. · Finding · SALICYLIC ACID

  5. Irritation
    Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne

    Trials of topical salicylic acid for acne reported application-site reactions such as scaling and redness.

    Review article · 2020 · People with mild to moderate acne in the included trials · Topical salicylic acid in acne trials, mainly leave-on use over eight weeks or longer. · The review graded the salicylic acid adverse-event comparisons as very low certainty.

    PMID 32356369